Erick Moyneur

Title: The Innovative Contributions of Erick Moyneur

Introduction

Erick Moyneur is a notable inventor based in L'ange-Gardien, CA. He has made significant contributions to the field of medical science, particularly in the area of women's health. His work focuses on innovative solutions aimed at reducing health risks for postmenopausal women.

Latest Patents

Moyneur holds a patent for the invention titled "Reduction of the incidence or recurrence of breast cancer in postmenopausal women treated with intravaginal sex steroid precursor." This patent relates to the intravaginal use of sex steroid precursors, such as DHEA, to lower the incidence or recurrence of breast cancer in postmenopausal women. The recommended dosage is limited to 25 mg per day or less, and the patent also discloses the administration of selective estrogen receptor modulators for enhanced effectiveness.

Career Highlights

Erick Moyneur is associated with Endorecherche, Inc., where he has been able to apply his innovative ideas in a practical setting. His work has the potential to significantly impact the lives of many women by providing safer treatment options.

Collaborations

Moyneur has collaborated with esteemed colleagues such as Fernand Labrie and Alain Dury. These partnerships have likely contributed to the advancement of his research and the successful development of his patent.

Conclusion

Erick Moyneur's contributions to medical science, particularly in the realm of breast cancer treatment for postmenopausal women, highlight the importance of innovation in healthcare. His patent reflects a commitment to improving women's health and showcases the potential of intravaginal therapies.